To keep connected with us please login with your personal info
There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form.
It uses a dictionary of over 200 Latin words, combined with a handful of model sentence structures, to generate Lorem Ipsum which looks reasonable.
Jozicular Oncology’s goal is to eradicate cancer by developing personalized immunotherapies to fight multiple cancer types. Our approach focuses on the individual nature of a patient’s tumor and seeks.
These antigens, called tumor-specific neoantigens, offer attractive therapeutic targets because they are non-self and tumor-specific, and are key targets.
PolyXen™
XCART Platform
XBIO-101 (sodium cridanimod)
Anti C5a Technology
Routine FFPE clinical biopsy as input material
Jozicular EDGE™ AI model for tumor antigen prediction
Tumor exome Normal exome Tumor transcriptome
Patient specific predicted neoantigens inserted
To receive email releases, simply provide us with your email address below.